Mark Cuban’s drug company started with an ambitious premise: to circumvent middlemen to offer cheaper costs to patients.
To do so, the company has had to grapple with which parts of the supply chain to develop themselves, and which to outsource using unusually transparent contracts, Mark Cuban Cost Plus Drug Company Founder and CEO Alex Oshmyansky said Thursday at STAT’s Breakthrough Science Summit.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
